Skip to main content
All lobbying clients

CURRAX PHARMACEUTICALS LLC

Lobbying client · Tennessee · filed 2025 to 2026

Specialty pharmaceutical business

$310,000 Reported spend
7 Filings counted
1 Outside firm hired
2 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (56944), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 2
  • H.R. 4231
    Treat and Reduce Obesity Act of 2025
    4 filings
  • S. 1973
    Treat and Reduce Obesity Act of 2025
    4 filings
 Reported by year 2 years
  • 2026 $100,000 3 filings
  • 2025 $210,000 4 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Centers For Medicare and Medicaid Services (CMS) 4
  • Executive Office of the President (EOP) 4
  • Health & Human Services, Dept of (HHS) 4

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem